Us Physicalrapy Stock Analysis
| USPH Stock | USD 84.48 1.10 1.29% |
IPO Date 28th of May 1992 | 200 Day MA 79.7992 | 50 Day MA 80.8754 | Beta 1.298 |
US Physicalrapy holds a debt-to-equity ratio of 0.572. As of now, US Physicalrapy's Long Term Debt is increasing as compared to previous years. The US Physicalrapy's current Long Term Debt Total is estimated to increase to about 142 M, while Debt To Equity is projected to decrease to 0.50. With a high degree of financial leverage come high-interest payments, which usually reduce US Physicalrapy's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
US Physicalrapy's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. US Physicalrapy's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps USPH Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect US Physicalrapy's stakeholders.
For many companies, including US Physicalrapy, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for US Physicalrapy, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, US Physicalrapy's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 2.5839 | Enterprise Value Ebitda 13.8733 | Price Sales 1.7327 | Shares Float 14.9 M | Dividend Share 1.79 |
US Physicalrapy is undervalued with Real Value of 93.24 and Target Price of 105.33. The main objective of US Physicalrapy stock analysis is to determine its intrinsic value, which is an estimate of what US Physicalrapy is worth, separate from its market price. There are two main types of US Physicalrapy's stock analysis: fundamental analysis and technical analysis.
The US Physicalrapy stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and US Physicalrapy's ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. USPH Stock Analysis Notes
About 98.0% of the company outstanding shares are owned by institutional investors. The book value of US Physicalrapy was at this time reported as 33.12. The company last dividend was issued on the 17th of November 2025. US Physicalrapy had 3:2 split on the 29th of June 2001. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is based in Houston, Texas. US Physical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 3158 people. For more information please call Christopher Reading at 713 297 7000 or visit https://www.usph.com.US Physicalrapy Quarterly Total Revenue |
|
US Physicalrapy Investment Alerts
| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from kalkinemedia.com: U.S. Physical Therapys Operating Model Gains Fresh Market Interest |
USPH Largest EPS Surprises
Earnings surprises can significantly impact US Physicalrapy's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2001-03-09 | 2000-12-31 | 0.09 | 0.1 | 0.01 | 11 | ||
1999-08-05 | 1999-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
1997-05-13 | 1997-03-31 | 0.03 | 0.04 | 0.01 | 33 |
US Physicalrapy Environmental, Social, and Governance (ESG) Scores
US Physicalrapy's ESG score is a quantitative measure that evaluates US Physicalrapy's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of US Physicalrapy's operations that may have significant financial implications and affect US Physicalrapy's stock price as well as guide investors towards more socially responsible investments.
USPH Stock Institutional Investors
| Shares | Rockefeller Capital Management L.p. | 2025-06-30 | 356.9 K | Geode Capital Management, Llc | 2025-06-30 | 352.9 K | Envestnet Asset Management Inc | 2025-06-30 | 346.2 K | Bahl & Gaynor Inc. | 2025-06-30 | 321.6 K | Point72 Asset Management, L.p. | 2025-06-30 | 275.7 K | Northern Trust Corp | 2025-06-30 | 235.1 K | Bank Of America Corp | 2025-06-30 | 179 K | Wells Fargo & Co | 2025-06-30 | 175.6 K | Fmr Inc | 2025-06-30 | 165.9 K | Blackrock Inc | 2025-06-30 | 2.2 M | Kayne Anderson Rudnick Investment Management Llc | 2025-06-30 | 1.5 M |
USPH Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.3 B.USPH Profitablity
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.10 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.08 |
Management Efficiency
US Physicalrapy has return on total asset (ROA) of 0.0426 % which means that it generated a profit of $0.0426 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0844 %, meaning that it created $0.0844 on every $100 dollars invested by stockholders. US Physicalrapy's management efficiency ratios could be used to measure how well US Physicalrapy manages its routine affairs as well as how well it operates its assets and liabilities. As of now, US Physicalrapy's Return On Tangible Assets are decreasing as compared to previous years. The US Physicalrapy's current Return On Equity is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.05. As of now, US Physicalrapy's Total Current Assets are increasing as compared to previous years. The US Physicalrapy's current Non Currrent Assets Other is estimated to increase to about 6.2 M, while Net Tangible Assets are forecasted to increase to (245.4 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 45.35 | 47.62 | |
| Tangible Book Value Per Share | (6.67) | (6.34) | |
| Enterprise Value Over EBITDA | 16.47 | 17.29 | |
| Price Book Value Ratio | 3.14 | 4.65 | |
| Enterprise Value Multiple | 16.47 | 17.29 | |
| Price Fair Value | 3.14 | 4.65 | |
| Enterprise Value | 144.3 M | 151.5 M |
Effective leadership at US Physicalrapy drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Technical Drivers
As of the 9th of February, US Physicalrapy owns the Risk Adjusted Performance of 0.0127, mean deviation of 1.68, and Downside Deviation of 3.01. Concerning fundamental indicators, the technical analysis model makes it possible for you to check potential technical drivers of US Physicalrapy, as well as the relationship between them.US Physicalrapy Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in US Physicalrapy price series with the more recent values given greater weights.
US Physicalrapy Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific US Physicalrapy insiders, such as employees or executives, is commonly permitted as long as it does not rely on US Physicalrapy's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases US Physicalrapy insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
US Physicalrapy Outstanding Bonds
US Physicalrapy issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. US Physicalrapy uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most USPH bonds can be classified according to their maturity, which is the date when US Physicalrapy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
US Physicalrapy Predictive Daily Indicators
US Physicalrapy intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of US Physicalrapy stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1987.85 | |||
| Daily Balance Of Power | (0.57) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 84.46 | |||
| Day Typical Price | 84.47 | |||
| Price Action Indicator | (0.53) | |||
| Period Momentum Indicator | (1.10) |
US Physicalrapy Corporate Filings
8K | 4th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 29th of January 2026 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 7th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 25th of November 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 24th of November 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 18th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 12th of November 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of November 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
US Physicalrapy Forecast Models
US Physicalrapy's time-series forecasting models are one of many US Physicalrapy's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary US Physicalrapy's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.US Physicalrapy Bond Ratings
US Physicalrapy financial ratings play a critical role in determining how much US Physicalrapy have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for US Physicalrapy's borrowing costs.| Piotroski F Score | 5 | Healthy | View |
| Beneish M Score | (2.29) | Unlikely Manipulator | View |
US Physicalrapy Debt to Cash Allocation
As US Physicalrapy follows its natural business cycle, the capital allocation decisions will not magically go away. US Physicalrapy's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
US Physicalrapy currently holds 295.23 M in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. US Physicalrapy has a current ratio of 1.4, which is within standard range for the sector. Note, when we think about US Physicalrapy's use of debt, we should always consider it together with its cash and equity.US Physicalrapy Total Assets Over Time
US Physicalrapy Assets Financed by Debt
The debt-to-assets ratio shows the degree to which US Physicalrapy uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.US Physicalrapy Debt Ratio | 22.0 |
US Physicalrapy Corporate Bonds Issued
Most USPH bonds can be classified according to their maturity, which is the date when US Physicalrapy has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
USPH Net Debt
Net Debt |
|
About USPH Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how US Physicalrapy prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling USPH shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as US Physicalrapy. By using and applying USPH Stock analysis, traders can create a robust methodology for identifying USPH entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.08 | 0.09 | |
| Operating Profit Margin | 0.08 | 0.07 | |
| Net Profit Margin | 0.04 | 0.04 | |
| Gross Profit Margin | 0.21 | 0.29 |
Current USPH Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. USPH analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. USPH analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 105.33 | Strong Buy | 7 | Odds |
Most USPH analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand USPH stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of US Physicalrapy, talking to its executives and customers, or listening to USPH conference calls.
USPH Stock Analysis Indicators
US Physicalrapy stock analysis indicators help investors evaluate how US Physicalrapy stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading US Physicalrapy shares will generate the highest return on investment. By understating and applying US Physicalrapy stock analysis, traders can identify US Physicalrapy position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 152.8 M | |
| Long Term Debt | 142.5 M | |
| Common Stock Shares Outstanding | 15.1 M | |
| Total Stockholder Equity | 488.9 M | |
| Total Cashflows From Investing Activities | -149.4 M | |
| Tax Provision | 14.6 M | |
| Quarterly Earnings Growth Y O Y | 0.236 | |
| Property Plant And Equipment Net | 166.1 M | |
| Cash And Short Term Investments | 41.4 M | |
| Cash | 41.4 M | |
| Accounts Payable | 5.9 M | |
| Net Debt | 253.9 M | |
| 50 Day M A | 80.8754 | |
| Total Current Liabilities | 116.3 M | |
| Other Operating Expenses | 608.1 M | |
| Non Current Assets Total | 1 B | |
| Forward Price Earnings | 30.8642 | |
| Non Currrent Assets Other | 5.2 M | |
| Stock Based Compensation | 7.8 M |
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |